Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Enright Patrick G
Relationship:   10% Owner
City:   Burlingame
State:   CA
   
Insider Summary:
  
   
Companies Owned :   16    
Direct Shares   3,308,185    

Indirect Shares

   27,432,603      
Direct Value   $9,946,560    

Indirect Value

   $114,800,011      
Total Shares   30,740,788      
Total Value   $124,746,571      


Molecular Templates, Inc. $298 Sequenom Inc $0 Corcept Therapeutics Inc $7,648,373 Jazz Pharmaceuticals Inc $2,288,769 Aptinyx Inc. $9,120 Eargo, Inc. $0 Molecular Templates, Inc. $298 Sequenom Inc $0 Corcept Therapeutics Inc $7,648,373 Jazz Pharmaceuticals Inc $2,288,769 Aptinyx Inc. $9,120 Eargo, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    6   
    1    

     Stock price went up :
    5   
    1    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   5.0   
   1.0   
     Percentage Gain/Loss :
   95.0%
 101.2%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Molecular Templates, Inc. MTEM Director 2006-04-20 496 2007-03-01 0    Premium*  
            Sequenom Inc SQNM Director 2006-12-07 771 2006-12-07 3,333,333    Premium*  
            Corcept Therapeutics Inc CORT Director 2017-03-16 272,281 2017-03-16 114,675    Premium*  
            Jazz Pharmaceuticals Inc JAZZ Director 2023-08-14 20,946 2022-08-08 2,000    Premium*  
            Esperion Therapeutics, Inc. ESPR Director 2013-07-01 0 2015-03-19 18,361    Premium*  
            Collegium Pharmaceutical, Inc COLL 10% Owner 2015-05-12 0 2015-05-12 65,270    Premium*  
            Aimmune Therapeutics, Inc. AIMT Director 2020-10-13 0 2020-10-10 0    Premium*  
            Aptinyx Inc. APTX Director 2020-01-10 95,000 2020-01-10 3,356,746    Premium*  
            Tricida, Inc. TCDA 2018-07-02 0 2018-07-02 3,019,734    Premium*  
            Venus Concept Inc VERO 10% Owner 0 2019-11-07 3,666,119    Premium*  
            89bio, Inc. ETNB 10% Owner 2019-11-11 0 2020-11-16 891    Premium*  
            Sierra Oncology Inc SRRA 10% Owner 2020-01-29 0 2022-01-25 1,964,771    Premium*  
            Inozyme Pharma, Inc. INZY 10% Owner 2020-07-28 0 2022-04-19 4,174,379    Premium*  
            Eargo, Inc. EAR 10% Owner 2021-04-14 2,918,691 2021-04-14 5,012    Premium*  
            Vera Therapeutics, Inc. VERA Director, 10% Owner 2021-05-18 0 2023-02-06 5,144,212    Premium*  
            Lexeo Therapeutics, Inc. LXEO 10% Owner 2023-11-07 0 2023-11-07 2,567,100    Premium*  
* Premium Members only  

Records found :    169         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SRRA Sierra Oncology Inc 10% Owner   –       –       •   2022-01-25 4 OE $13.20 $6,434,353 I/I 487,451 1,964,771 0 -
AIMT Aimmune Therapeutics, Inc... Director   –       •       •   2016-03-29 4 B $13.50 $1,089,135 I/I 78,504 7,513,134 2.25 -
ESPR Esperion Therapeutics, In... Director   –       •       •   2013-07-01 4 B $14.00 $3,033,464 I/I 216,676 38,011 2.25 -
VERA Vera Therapeutics, Inc. Director   –       •       •   2022-02-10 4 B $15.00 $4,999,995 I/I 333,333 3,429,927 2.25 -
AIMT Aimmune Therapeutics, Inc... Director   –       •       •   2015-08-11 4 B $16.00 $5,000,000 I/I 312,500 7,434,630 2.25 -
APTX Aptinyx Inc. Director   –       •      –    2018-06-25 4 B $16.00 $2,400,000 I/I 150,000 3,190,079 2.1 -
ETNB 89bio, Inc. 10% Owner   –       –       •   2019-11-11 4 B $16.00 $9,200,000 I/I 575,000 575,000 1.5 -
INZY Inozyme Pharma, Inc. 10% Owner   –       –       •   2020-07-28 4 B $16.00 $10,000,000 I/I 625,000 2,819,379 1.5 -
TCDA Tricida, Inc.   •       •       •   2018-07-02 4 B $19.00 $2,500,001 I/I 131,579 3,019,734 0.01 -
AIMT Aimmune Therapeutics, Inc... Director   –       •      –    2019-09-17 4 A $22.34 $279,216 D/D 12,500 45,561 0 -
ETNB 89bio, Inc. 10% Owner   –       –       •   2020-07-10 4 B $27.50 $2,999,975 I/I 109,090 2,600,877 1.5 %
ESPR Esperion Therapeutics, In... Director   –       •       •   2014-10-09 4 S $30.00 $28,290 I/I (943) 37,757 0 -
ESPR Esperion Therapeutics, In... Director   –       •       •   2014-10-07 4 S $30.04 $358,289 I/I (11,927) 37,776 0 -
ESPR Esperion Therapeutics, In... Director   –       •       •   2014-11-18 4 S $31.56 $161,346 I/I (5,104) 28,186 0 -
AIMT Aimmune Therapeutics, Inc... Director   –       •       •   2018-02-22 4 B $32.00 $498,976 D/D 15,593 22,869 3.92 -
ESPR Esperion Therapeutics, In... Director   –       •       •   2014-11-17 4 S $32.01 $15,804,823 I/I (482,026) 28,286 0 -
AIMT Aimmune Therapeutics, Inc... Director   –       •      –    2020-10-10 4 D $34.50 $3,163,547 I/I (91,697) 0 0 -
AIMT Aimmune Therapeutics, Inc... Director   –       •      –    2020-10-10 4 D $34.50 $2,434,355 D/D (70,561) 0 0 -
AIMT Aimmune Therapeutics, Inc... Director   –       •      –    2020-10-13 4 D $34.50 $270,480 D/D (7,840) 0 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2017-12-11 4 OE $46.83 $578,655 D/D 9,000 25,339 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2012-01-11 4 D $48.60 $729,729 D/D (15,015) 49,985 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2013-01-09 4 AS $56.52 $333,447 I/I (5,900) 33,635 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2013-01-10 4 AS $56.52 $2,030,470 I/I (35,922) 32,929 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2013-01-11 4 AS $56.54 $90,463 I/I (1,600) 32,898 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2013-01-15 4 AS $56.72 $1,317,534 I/I (23,228) 32,442 0 -
  169  Records found
  1   2   3   4   5  6   7      
  Page 5 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us